Nick Beije

<i>TP53</i> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

Bram De Laere, Steffi Oeyen, Markus Mayrhofer et al. · Clinical Cancer Research · 2018 · 161 citations · Full text

Application of circulating tumor DNA in prospective clinical oncology trials – standardization of preanalytical conditions

Lisanne F. van Dessel, Nick Beije, Jean Helmijr et al. · Molecular Oncology · 2017 · 155 citations · Full text

Dna Analysis, Pathology, Optimal Ctdna Quality +21

Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases

Nick Beije, Jean Helmijr, Marjolein J.A. Weerts et al. · Molecular Oncology · 2016 · 74 citations · Full text

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor

Nick Beije, Wendy Onstenk, Jaco Kraan et al. · Neoplasia · 2016 · 58 citations · Full text

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients

Nick Beije, Anieta M. Sieuwerts, Jaco Kraan et al. · Molecular Oncology · 2017 · 56 citations · Full text

Breast Oncology, Estrogen Receptor, Gynecology +19